Loading...

Nanoliposomal delivery of cytosolic phospholipase A(2) inhibitor arachidonyl trimethyl ketone for melanoma treatment

Drug resistance and toxicity are major limitations of cancer treatment and frequently occurs in melanoma therapy. Nanotechnology can decrease drug resistance by improving drug delivery, with limited toxicity. This study details the development of nanoparticles containing arachidonyl trifluoromethyl...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine
Main Authors: Gowda, Raghavendra, Dinavahi, Saketh S., Iyer, Soumya, Banerjee, Shubhadeep, Neves, Rogerio I., Pameijer, Colette R., Robertson., Gavin P.
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5899023/
https://ncbi.nlm.nih.gov/pubmed/29317343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2017.12.020
Tags: Add Tag
No Tags, Be the first to tag this record!